Relapsing Fever in Emergency Medicine
- Author: Bobak Zonnoor , MD; Chief Editor: Jeter (Jay) Pritchard Taylor, III, MD more...
Relapsing fever is a bacterial infection caused by spirochetes of the genus Borrelia. It is characterized by recurring episodes of high fever, headache, and muscle and joint aches. The high fevers of presenting patients spontaneously abate and then recur. This characteristic pattern of remission and relapse not only gives relapsing fever its name but also allows it to be differentiated clinically from other febrile illnesses as it has since the 1840s.
There are two types of relapsing fever: tick-borne relapsing fever (TBRF) and louse-borne relapsing fever (LBRF).
Tick-borne relapsing fever
The two main Borrelia species in North America include Borrelia hermsii (in the west), and Borrelia turicatae (southwest and south central). Relapsing fever caused by these species is usually associated with sleeping in rustic, rodent-infested settings, especially in mountainous areas.
Louse-borne relapsing fever
Louse-borne relapsing fever is caused by Borrelia recurrentis, which is usually transmitted by the human body louse. Thus, louse-borne relapsing fever is generally restricted to refugee settings in developing countries.
Large outbreaks of louse-borne relapsing fever have occurred throughout the past century. These outbreaks usually occur following man-made breakdowns in public health, as typified by the epidemic following World War II that involved about 10 million people.
Relapsing fever is transmitted to humans by 2 vectors, ticks and lice. The human body louse, Pediculus humanus, is the specific vector (Pediculus pubis is not a vector). Louse-borne relapsing fever is more severe than the tick-borne variety.
Louse-borne relapsing fever is caused by B recurrentis, which is transmitted from human to human via the body louse. No animal reservoir exists. Lice that feed on infected humans acquire the Borrelia organisms that then multiply in the gut of the louse. When an infected louse feeds on an uninfected human, the organism gains access when the victim crushes the louse or scratches the area where the louse is feeding. B recurrentis infects the person via either abraded or intact skin (or mucous membranes) and then invades the bloodstream.
Soft ticks of the genus Ornithodoros spread the tick-borne variety. The responsible Borrelia species are identified closely with its tick vector and they share parallel nomenclature. (For example, Borrelia parkeri infects Ornithodoros parkeri; Borrelia hermsii is the agent transmitted by tick bite by Ornithodoros hermsii.) Soft ticks differ in two important ways from the more familiar hard ticks (eg, dog tick and deer tick). First, soft ticks feed for short periods (<30 minutes), and the Borrelia organisms are inoculated within minutes. This is an important distinction from other tick-borne diseases such as Lyme disease. Second, soft ticks do not search for a prey in tall grass or bush; instead, they live within rodent burrows, feeding as needed on the rodent as it sleeps.
Regardless of the mode of transmission, a spirochetemia develops. Borrelia organisms then invade the endothelium. This can produce a low-grade disseminated intravascular coagulation and thrombocytopenia. The relapse phenomenon occurs because of genetically programmed shifting of outer surface proteins of the Borrelia that allows a new clone to avoid destruction by antibodies directed against the majority of the original infecting organisms. Thus, the person clinically improves until the new clone multiplies sufficiently to cause another relapse. Tick-borne disease tends to have more relapses (average of 3) compared with the louse-borne variety (often just 1).
The recent resurgence of interest in Borrelia because of Lyme disease and, especially the recent publication of the genomic sequence of B burgdorferi, has led to advances in the understanding of the host-parasite interactions of the relapsing fever Borrelia.
Louse-borne relapsing fever is not endemic in the United States, although an occasional traveler presents with an imported case.
Few cases of tick-borne relapsing fever are reported in the United States; however, sporadic cases continue to occur. It is highly focal, with 13 counties producing 50% of cases. Most of these are found in the late spring and summer in the western mountainous states, south into California and Colorado and northwest into Washington. Undoubtedly, many cases occur that either are misdiagnosed or unreported.
Endemic foci of louse-borne relapsing fever occur in much of the world where war, poverty, and overcrowding exist; all of which are conditions that favor louse infestation. Civil wars, which result in large refugee camps, are also fertile ground for lice and relapsing fever.[2, 3, 4, 5, 6]
Louse-borne relapsing fever epidemics were common in Europe during the 20th century. Between 1919 and 1923, 13 million cases, resulting in 5 million deaths, occurred in social upheaval that overtook Russia and Eastern Europe. During World War II, a million cases occurred in North Africa. Today, louse-borne relapsing fever causes sporadic illness and outbreaks in sub-Saharan Africa, particularly in regions affected by war and in refugee camps.[7, 8, 9, 10]
Mortality rates from 30-70% are reported in untreated patients during epidemics of the louse-borne variety; the mortality rate falls to about 5% with treatment. This striking figure probably reflects the underlying malnutrition and coexisting infections that exist in these situations.
The mortality rate of patients with tick-borne relapsing fever who are treated is less than 1%.
A slight preponderance of female patients exists in louse-borne epidemics (60%); tick-borne relapsing fever occurs more often in males (60%) than in females. The latter figure probably reflects the greater likelihood of males being exposed to ticks through recreational and occupational activities.
A trend toward pediatric cases of both forms of relapsing fever exists. In the case of the louse-borne variety, this may reflect the general state of health in populations where relapsing fever is endemic. Regarding the tick-borne disease, this may reflect activities that lead to tick exposure.
CDC. Tick-borne Relapsing Fever (TBRF). CDC. Available at https://www.cdc.gov/relapsing-fever/. October 15, 2015; Accessed: June 2, 2016.
Palma M, Lopes de Carvalho I, Figueiredo M, Amaro F, Boinas F, Cutler SJ, et al. Borrelia hispanica in Ornithodoros erraticus, Portugal. Clin Microbiol Infect. 2011 Jun 30. [Medline].
Yabsley MJ, Parsons NJ, Horne EC, Shock BC, Purdee M. Novel relapsing fever Borrelia detected in African penguins (Spheniscus demersus) admitted to two rehabilitation centers in South Africa. Parasitol Res. 2011 Aug 26. [Medline].
Reller ME, Clemens EG, Schachterle SE, Mtove GA, Sullivan DJ, Dumler JS. Multiplex 5' nuclease-quantitative PCR for diagnosis of relapsing fever in a large Tanzanian cohort. J Clin Microbiol. 2011 Sep. 49(9):3245-9. [Medline]. [Full Text].
Croche Santander B, Sánchez Carrión A, Campos E, Toro C, Marcos L, Vargas JC, et al. [Tick-borne relapsing fever in a rural area of southern Spain.]. An Pediatr (Barc). 2013 Dec 12. [Medline].
Moran-Gilad J, Levine H, Schwartz E, Bartal C, Huerta-Hartal M, Schwaber MJ, et al. Postexposure prophylaxis of tick-borne relapsing Fever: lessons learned from recent outbreaks in Israel. Vector Borne Zoonotic Dis. 2013 Nov. 13(11):791-7. [Medline].
Cutler SJ, Abdissa A, Trape JF. New concepts for the old challenge of African relapsing fever borreliosis. Clin Microbiol Infect. 2009 May. 15 (5):400-6. [Medline].
Hayes EB, Dennis DT . p.991-995. Relapsing fever. Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL, eds. Harrison's Principles of Internal Medicine. 16th edition. 2004. 991-5.
Rahlenbeck SI, Gebre-Yohannes A. Louse-borne relapsing fever and its treatment. Trop Geogr Med. 1995. 47 (2):49-52. [Medline].
Raoult D, Roux V. The body louse as a vector of reemerging human diseases. Clin Infect Dis. 1999 Oct. 29 (4):888-911. [Medline].
Blevins SM, Greenfield RA, Bronze MS. Blood smear analysis in babesiosis, ehrlichiosis, relapsing fever, malaria, and Chagas disease. Cleve Clin J Med. 2008 Jul. 75 (7):521-30. [Medline].
Hovius JW, de Wever B, Sohne M, Brouwer MC, Coumou J, Wagemakers A, et al. A case of meningoencephalitis by the relapsing fever spirochaete Borrelia miyamotoi in Europe. Lancet. 2013 Aug 17. 382 (9892):658. [Medline].
Parola P, Raoult D. Ticks and tickborne bacterial diseases in humans: an emerging infectious threat. Clin Infect Dis. 2001 Mar 15. 32 (6):897-928. [Medline].
Perine PL, Parry EH, Vukotich D, Warrell DA, Bryceson AD. Bleeding in louse-borne relapsing fever. I. Clinical studies in 37 patients. Trans R Soc Trop Med Hyg. 1971. 65 (6):776-81. [Medline].
Sah RP, Wilson ME, Seningen J, Bhagra A. Relapsing fevers and lymphadenopathy in a young woman. BMJ Case Rep. 2013 Jul 13. 2013:[Medline].
Fukunaga M, Okada K, Nakao M, Konishi T, Sato Y. Phylogenetic analysis of Borrelia species based on flagellin gene sequences and its application for molecular typing of Lyme disease borreliae. Int J Syst Bacteriol. 1996 Oct. 46 (4):898-905. [Medline].
Chohan IS. Tick-borne relapsing fever in Kashmir: mice inoculation--a diagnostic method of choice. Indian J Pathol Bacteriol. 1967 Jul. 10 (3):289-94. [Medline].
Barbour AG. Clinical features and management of relapsing fever. UpToDate. Accessed: November 25, 2008.
Dworkin MS, Schwan TG, Anderson DE Jr, Borchardt SM. Tick-borne relapsing fever. Infect Dis Clin North Am. 2008 Sep. 22 (3):449-68, viii. [Medline].
Fekade D, Knox K, Hussein K, et al. Prevention of Jarisch-Herxheimer reactions by treatment with antibodies against tumor necrosis factor alpha. N Engl J Med. 1996 Aug 1. 335(5):311-5. [Medline].
Guerrier G, Doherty T. Comparison of antibiotic regimens for treating louse-borne relapsing fever: a meta-analysis. Trans R Soc Trop Med Hyg. 2011 Sep. 105(9):483-90. [Medline].
Hasin T, Davidovitch N, Cohen R, et al. Postexposure treatment with doxycycline for the prevention of tick-borne relapsing fever. N Engl J Med. 2006 Jul 13. 355(2):148-55. [Medline].
Southern PM, Sandford JP. Relapsing fever: a clinical and microbiological review. Med. 1969. 48:129-43.
Anda P, Sanchez-Yebra W, del Mar Vitutia M, et al. A new Borrelia species isolated from patients with relapsing fever in Spain. Lancet. 1996 Jul 20. 348(9021):162-5. [Medline].
Cadavid D, Barbour AG. Neuroborreliosis during relapsing fever: review of the clinical manifestations, pathology, and treatment of infections in humans and experimental animals. Clin Infect Dis. 1998 Jan. 26(1):151-64. [Medline].
Centers for Disease Control and Prevention (CDC). Acute respiratory distress syndrome in persons with tickborne relapsing fever--three states, 2004-2005. MMWR Morb Mortal Wkly Rep. 2007 Oct 19. 56(41):1073-6. [Medline].
Dworkin MS, Anderson DE Jr, Schwan TG, et al. Tick-borne relapsing fever in the northwestern United States and southwestern Canada. Clin Infect Dis. 1998 Jan. 26(1):122-31. [Medline].
Dworkin MS, Schwan TG, Anderson DE Jr, Borchardt SM. Tick-borne relapsing fever. Infect Dis Clin North Am. 2008 Sep. 22(3):449-68, viii. [Medline].
Horton JM, Blaser MJ. The spectrum of relapsing fever in the Rocky Mountains. Arch Intern Med. 1985 May. 145(5):871-5. [Medline].
Nordstrand A, Barbour AG, Bergstrom S. Borrelia pathogenesis research in the post-genomic and post-vaccine era. Curr Opin Microbiol. 2000 Feb. 3(1):86-92. [Medline].
Paul WS, Maupin G, Scott-Wright AO, et al. Outbreak of tick-borne relapsing fever at the north rim of the Grand Canyon: evidence for effectiveness of preventive measures. Am J Trop Med Hyg. 2002 Jan. 66(1):71-5. [Medline].
Raoult D, Roux V. The body louse as a vector of reemerging human diseases. Clin Infect Dis. 1999 Oct. 29(4):888-911. [Medline].